I'd like to look at downtown development and who Johns Hopkins thinks is a good fit for Baltimore. After the crash Baltimore saw all the Wall Street banks set up shop =====from Morgan Stanley to Wells Fargo to Deutsche Bank and HBS-----all the dirtiest of the financial players in last decades frauds now home to Enterprise Zones in Baltimore's downtown. The consolidation of the bad and ugly! A dash of Caesar's casino gambling makes the rogue city-scape complete.
RBS Citizens Bank locations in Maryland outside larger counties (Frederick, Arnold, Baltimore, Germantown, ...)
Citizens Financial Group, Inc. is a British-owned American bank headquartered in Providence, Rhode Island, which operates in the states of Connecticut, Delaware, Illinois, Massachusetts, Michigan, New Hampshire, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Vermont. Citizens is a wholly owned subsidiary of The Royal Bank of Scotland Group (RBS), headquartered in Edinburgh, Scotland. Following the financial rescue of RBS, the company's controlling shareholder is currently the British government. As of 2011, Citizens was the 15th-largest bank in the United States.
Now, who better to market Hopkins new bio-tech PHARMA patenting machine than a global PHARMA corporation from a third world nation. Now, we are loaded with medical lawsuits against PHARMA from US based corporations that the FDA approves without knowing efficacy----so what do you think will happen with our PHARMA safety and quality with this Indian PHARMA which Hopkins probably owns major shares in?
What Hopkins and the pols in the Maryland Assembly and Congress are working towards with TPP is allowing this global corporation from India to manufacture under its nations lack of regulations and in the future setting up manufacturing bringing their employees from India to work here in Baltimore as if they were still in India. So, what happens to Baltimore residents when all labor is brought from overseas or around the nation? We have huge unemployment, poverty deepens, and crime and violence escalate. That's OK says Hopkins----we just passed a prison labor bill that will let Baltimore residents jailed work for free as prison labor.
But it is progressive welcome immigrants you say----not if the plan has them working as they do in India.
Lupin Pharmaceuticals, Inc
'Our mission is to become a transnational pharmaceutical company through the development and introduction of a wide portfolio of branded and generic products in key markets'.
. is the U.S. wholly owned subsidiary of Lupin Limited, which is among the top five pharmaceutical companies in India. Through our sales and marketing headquarters in Baltimore, MD, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies.
Lupin Limited, headquartered in Mumbai, India, is strongly research focused. It has a program for developing New Chemical Entities. The company has a state-of-the-art R&D center in Pune and is a leading global player in Anti-TB, Cephalosporins (anti-infectives) and Cardiovascular drugs (ACE-inhibitors and cholesterol reducing agents) and has a notable presence in the areas of diabetes, anti-inflammatory and respiratory therapy.
We are building on our parent company's strengths of vertical integration in discovery research, process chemistry, active pharmaceutical ingredient production, formulation development and regulatory filings. Lupin Pharmaceuticals, Inc. is committed to achieving its vision and mission of becoming an innovation led transnational pharmaceutical company.
Vinita Gupta, CEO of Lupin Pharmaceuticals, Inc. says "founded on the strengths of our parent company Lupin Limited, Lupin Pharmaceuticals, Inc. intends to bring a portfolio of generics as well as branded products to the US market."
For the financial year ended March 2012, Lupin Limited's Revenues & Profit after Tax were Rs.69,597 Mn (US $1,392 Mn) & Rs. 8,676 Mn (US $ 174 Mn) respectively. Please visit http://www.lupinworld.com for more information about Lupin Limited.
Below you see the types of disclaimers that will frequent our legal abilities to gain justice from harm done by medical devices and PHARMA from these global corporations that will be immune from US laws that take away from profit with Trans Pacific Trade Pact. So, the citizens of Maryland have a source of generics that operates as it does in India with the ability to take on new patents from Hopkins that will be mass produced and patented with little FDA oversight, manufactured in India and imported to the US all as a global corporation with profits overseas. If TPP is made official this global corporation will be telling the citizens of Baltimore what they will and will not do and forget taxes for goodness sake.
What Baltimore could have is a small generic drug manufacturing plant that hires for good jobs and supplies quality US PHARMA.
Newsroom Lupin is granted USFDA approval for Levetiracetam Tablets
Baltimore, MD, January 16, 2009:Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received final approval for the Company's Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets 250mg, 500mg, 750 mg and 1000 mg from the U.S. Food and Drug Administration (USFDA). Commercial shipments of the product have commenced.
Lupin's Levetiracetam tablets are the AB-rated generic equivalent of UCB Pharmaceuticals' Keppra® tablets, indicated as adjunctive therapy in the treatment of certain types of seizures associated with epilepsy. Keppra tablets had annual sales of approximately $ 1.2 billion (USD) for the twelve months ended September 2008, based on IMS Health sales data.
Headquartered in Mumbai, India, Lupin Limited is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations and APIs for the developed and developing markets of the world. The Company has secured global leadership position in Anti-TB and Cephalosporins and has a significant presence in the areas of Cardiovasculars (prils and statins), Diabetology, Asthma and NSAIDs.
The Company's R&D endeavors have resulted in significant progress in its NCE program. The Company's foray into New Drug Delivery Systems has resulted in the development of platform technologies that are being used to develop value-added generic pharmaceuticals.
For the financial year ended March 2008, the Lupin's Revenues and Profit after Tax were Rs.27,730 million (US$ 694 million) and Rs.4,083 million (US$ 102 million) respectively. Please visit http://www.lupinworld.com for more information about Lupin Ltd.
Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, which is among the top six Pharmaceutical companies in India. Through its sales and marketing headquarters in Baltimore, Maryland, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, affordable generic medicines trusted by healthcare professionals and patients across geographies. For more information, visit http://www.lupinpharmaceuticals.com.
Safe Harbor Statement under the U. S. Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements that involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Many of these risks, uncertainties and other factors include failure of clinical trials, delays in development, registration and product approvals, changes in the competitive environment, increased government control over pricing, fluctuations in the capital and foreign exchange markets and the ability to maintain patent and other intellectual property protection. The information presented in this release represents management's expectations and intentions as of this date. Lupin expressly disavows any obligation to update the information presented in this release.
*Keppra® is a registered trademark of UCB Pharmaceuticals.
Now, if you live in Maryland and especially Baltimore you are now soaked with advertisement for life insurance that covers you no matter what and guarantees you will get back what you put in. It is the subprime mortgage fraud of the insurance industry and it will fall on people with this coming bond market crash. Remember, AIG Insurance was the global corporations used by Wall Street to blow up with toxic mortgage insurance fraud------AIG created Credit Default Swaps CDS that they knew were going to blow up and Greenspan and Geithner made sure that taxpayers paid 100% on the dollar for these CDS on toxic subprime mortgage fraudulent loans. THIS IS ORGANIZED CRIME. Remember as well it is Ivy League schools like Johns Hopkins who spun off all of AIG's assets before the crash giving them billions of dollars in HighStar investment firm from the massive subprime loan frauds in cities like Baltimore. So, Hopkins through AIG profited from all of the subprime mortgage loan fraud in the Maryland region----think Baltimore. City Hall helped create the conditions to defraud Baltimore citizens with this subprime loan scam. Baltimore City Hall working for Hopkins as usual. So, you see locally what this massive fraud looks like while the news simply speaks of AIG and going bankrupt.
What does that have to do with TRANSAMERICA? Well, more than likely TransAmerica has found its way to Baltimore because it will be the next AIG ----this time with the life insurance/pension insurance/credit bond insurance that is making it rich today. Baltimore is again ground zero for investment in all these vehicles as is all of the development tied with credit bonds. When the bond market crashes next year-----Trans America will be taken out because of its Credit Default Swaps for these credit bond financial instruments like Baltimore school building and State Center, and Baltimore Public Housing deals. THERE SHE GOES-----
TRANSAMERICA BANKRUPTED JUST LIKE AIG AND ALL OF ITS CDS WILL BE PAID TO INVESTMENT FIRMS---BUT ALL OF THE CONSUMERS TIED TO ITS PRODUCT LOSE ALL, INCLUDING THE MUNICIPAL BONDS AND PENSIONS.
This is simply a prediction but given the past and the players from last time----I bet TransAmerica will be the insurance corporation tagged for the next global bankruptcy. It, like AIG has global accounts and as with AIG a bankruptcy will take the world's money with it. They will spin off all the assets before taking it to bankruptcy. It is all planned and it is all illegal fraud----public malfeasance as our pols know what is happening just as I do!
Below you see who now owns TransAmerica----a Dutch corporation. Remember as well as a Dutch corporation they will after Trans Pacific Trade Pact be able to ignore all US labor and justice laws and operate as they do overseas. Wonder if they brought their own people from the Netherlands----no job creation there!
Founded1983HeadquartersThe Hague, NetherlandsArea servedWorldwideKey peopleAlex Wynaendts (CEO)
Rob Routs (Chairman of the supervisory board)ServicesLife insurance, asset management, pensionsRevenue€29,937 Billion (2012)Profit€1,571 Billion (2012)Total assets€366,118 Billion (end 2012)Employees24,407 (end 2012)Websitewww.aegon.com
Aegon N.V. is a multinational life insurance, pensions and asset management company headquartered in The Hague, Netherlands. At the end of 2012, Aegon companies employed approximately 24,000 people worldwide, serving millions of customers.
In July 1999, Aegon acquired Transamerica, one of the best-known insurers in the United States, and a company with a rich history of its own.
Transamerica's History (external link)Transamerica's history dates back to 1904, when Amadeo Giannini founded the Bank of Italy in San Francisco, California.
The bank served the working class residents of the city, including many Italians living in the North Beach neighborhood. The bank survived the San Francisco earthquake and fire of 1906 and was one of the first to offer loans to businesses to help rebuild the city.
After years of expansion, the Bank of Italy merged with the Bank of America in the 1920s. The bank assumed the name of Bank of America.
In 1930, Gianni acquired a major insurance company, Occidental Life Insurance, through a holding company he named Transamerica. Occidental had been founded soon after Gianni’s Bank of Italy – in 1906, also on the West Coast.
The Transamerica PyramidAfter decades of expansion, Transamerica commissioned architect William Pereira to design a new headquarters in San Francisco. The Transamerica Pyramid was completed in 1972, and remains San Francisco's tallest building.
Transamerica's headquarters are no longer in San Francisco, however the Pyramid is still owned by Aegon and remains an integral part of Transamerica's logo.
Aegon acquired Transamerica in 1999. It was the largest purchase ever made by a Dutch company overseas and the second largest in the US insurance industry.
Transamerica operates under its own brand name in North America, and remains one of the most-familiar names in the American insurance industry.
Below we see all the bad players from the last crisis-----look, there is RBS now all over Maryland. The most costly bailout was AIG as will be this next insurance industry that insures all the fraudulent credit bond deals. 100% payout on Credit Default Swaps while all other debt is written off. We can bet that America's Ivy League endowments are right there with these insurance corporations ready to bankrupt-----like TransAmerica and Johns Hopkins!
This is what our downtown is being filled with courtesy of Baltimore Development and Johns Hopkins and their employees at Baltimore City Hall. It involves the most criminal of businesses and we know that massive fraud is happening openly in these Baltimore headquarters just as if these corporations were in their third world nation.
ALL WE NEED TO DO IS RUN AND VOTE FOR LABOR AND JUSTICE IN PRIMARIES AT ALL LEVELS AND GET RID OF THESE CORPORATE POLS----WE CAN REVERSE THESE DEALS!
December 26, 2013 7:14 pm
Insurers may be at the centre of the next big crisis
By Patrick Jenkins
As banks are finding some business too costly, insurers are moving in, writes Patrick Jenkins
It would make a good pub quiz question: what was the most costly bailout of the 2008 financial crisis? Royal Bank of Scotland? Citigroup? Many assume so. Of course, the biggest failure of them all was not a bank at all, but insurer AIG.In total, AIG needed $182bn of bailout money from the US government – more than twice as much as the next biggest casualty, RBS – although by last year, like most of the American bailout cases, the federal investment had turned a profit. The fact remains, however, that the biggest financial sector collapse in the history of capitalism was a group that was nominally an insurer, but one that diversified so fast that it became impossible to manage or regulate.
In the aftermath of the financial crisis, politicians, regulators and the general public have focused almost obsessively on the banks. But the recent troubles of Britain’s RSA – five years after AIG’s disastrous collapse – are a useful reminder that insurers need watching, too.
Thankfully the UK’s biggest non-life insurer is not a vast company – RSA has barely £23bn of assets compared with the $1tn balance sheet AIG had when it failed. It is also relatively straightforward, largely writing insurance cover on buildings and cars rather than anything more rarefied. Nor is there any suggestion, despite a capital need estimated at up to £1bn, that RSA’s problems are insoluble.
Nevertheless the case of RSA, like AIG before it, should sound alarms. The emergence of a black hole in the group’s Irish business is a reminder that judging risk and accounting for it fairly can be even harder for an insurer than for a bank.
I have swampland in Florida is you believe these people didn't know what was coming-----we all knew what was coming as we do right now! AIG had insured most of the toxic subprime mortgages for goodness sake! MODEST RISK FOR GOODNESS SAKE!
Back in 2007, before the first signs of trouble had emerged at AIG, even senior management were blind to the dangers the group was running. In August of that year its then chief risk officer spoke of a “very modest and remote” chance that the mounting crisis in markets would spill over to hurt AIG. Martin Sullivan, its then chief executive, joked: “That’s why I am sleeping a little bit easier at night.”
Within four months, AIG’s accounts showed close to $2bn of unrealised losses. Within a year it had to be bailed out.
AIG’s problems were focused on insurance-like securities, which collapsed in value during the crisis, making a nonsense of accounting norms. But even accounting for simple insurance business can be unreliable. There is huge scope for judgment when deciding if premiums paid or promised should be treated as “earned” revenue. Reserving for losses can be even more subjective.
The ability of management and regulators to stay on top of the risks is harder still when the company is growing through mergers and acquisitions. AIG had been bullish about M&A. Likewise, RSA’s problem Irish business grew through aggressive deals. And so did the troubled Australian insurer QBE that, largely owing to problems within US businesses that it acquired, issued a massive profit warning earlier this month.
Today it is all the more important to shine a bright light on insurers as many prepare to broaden their business models away from plain old underwriting. In this, infamously, AIG was a pioneer, albeit a misguided one. Five years later – like other subsectors of the financial services industry such as asset managers and hedge funds – insurers and pension funds are looking to fill emerging gaps in the banking market left by the retreat of traditional lenders.
As banks have found some business rendered punitively expensive by new capital regulations, insurers are moving in to finance infrastructure projects and lend to companies. Some pension funds and life insurers have also branched out into the potentially lucrative business of betting on natural disasters by buying so-called catastrophe bonds.
In short, insurers are now a crucial part of the so-called shadow banking sector – an emerging hotch-potch of financial groups that are filling the vacuum left by shrinking banks.
All of this change presents new risks to insurance company investors, and potentially to the broader financial system – despite the widespread view that the financial crisis is all but over. The withdrawal of central banks’ massive doses of quantitative easing could yet disturb the fragile health of the financial system, particularly the fast-growing but relatively unobserved shadow banking sector.
To be fair, it is an issue that some regulators are alive to. In a parting interview in October from his role as deputy governor of the Bank of England, Paul Tucker told the Financial Times that regulators needed to “up their game” to avoid the “absolutely disastrous” recreation of old banking risks in other parts of the financial system. Global regulators on the Financial Stability Board have also highlighted the importance of supervising shadow banks. It recently included nine insurers among its list of globally systemic financial institutions that should be closely monitored and held to higher levels of capital adequacy.
But much more needs to be done. There are still no global standards on capital, amid persistently uneven accounting practices. In a symbolic contrast with the realm of banking, the bosses of insurance companies still appear able to reinvent themselves for the post-crisis world. Sir Fred Goodwin and Chuck Prince, the men who led RBS and Citigroup to near-collapse, have become pariahs of the financial sector. The same cannot be said of Mr Sullivan, the former AIG boss. This year he popped up as chairman of an insurer at the venerable Lloyd’s of London market.
The underwriter is called Antares – named after the red star – in case it comes up in a pub quiz.